Rigel Pharmaceuticals (RIGL) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,711.00 |
| Dec 31, 2025 | 8,318.00 |
| Sep 30, 2025 | 11,986.00 |
| Jun 30, 2025 | 12,417.00 |
| Mar 31, 2025 | 6,848.00 |
| Dec 31, 2024 | 10,118.00 |
| Sep 30, 2024 | 5,128.00 |
| Jun 30, 2024 | 3,213.00 |
| Mar 31, 2024 | 2,083.00 |
| Dec 31, 2023 | 3,777.00 |
| Sep 30, 2023 | 6,017.00 |
| Jun 30, 2023 | 4,751.00 |
| Mar 31, 2023 | 4,740.00 |
| Dec 31, 2022 | 1,061.00 |
| Sep 30, 2022 | 316.00 |
| Jun 30, 2022 | -69.00 |
| Mar 31, 2022 | 1,299.00 |
| Dec 31, 2021 | 10,368.00 |
| Sep 30, 2021 | 8,359.00 |
| Jun 30, 2021 | 5,942.00 |
| Mar 31, 2021 | 4,791.00 |
| Dec 31, 2020 | 1,271.00 |
| Sep 30, 2020 | 2,781.00 |
| Jun 30, 2020 | 3,726.00 |
| Mar 31, 2020 | 4,340.00 |
| Dec 31, 2019 | -1,073.00 |
| Sep 30, 2019 | 1,343.00 |
| Jun 30, 2019 | 330.00 |
| Mar 31, 2019 | -944.00 |
| Dec 31, 2018 | -3,008.00 |
| Sep 30, 2018 | -4,966.00 |
| Jun 30, 2018 | -5,464.00 |
| Mar 31, 2018 | -6,233.00 |
| Dec 31, 2017 | -6,220.00 |
| Sep 30, 2017 | -5,776.00 |
| Jun 30, 2017 | -5,261.00 |
| Mar 31, 2017 | -5,693.00 |
| Dec 31, 2016 | -8,083.00 |
| Sep 30, 2016 | -6,174.00 |